A Virtual Reality View—Evolving Standards of Care in Psoriasis: The Influence of Biologics on PASI Goals, Quality of Life, and Special Populations

View Activity

COURSE DIRECTOR

Crystal Aguh, MD
Director, Ethnic Skin Program
Assistant Professor, Department of Dermatology
Johns Hopkins School of Medicine
Baltimore, Maryland

PROGRAM OVERVIEW

This online activity will cover treatment options and management strategies for patients with psoriasis.

TARGET AUDIENCE

This activity is intended for dermatologists and other health care professionals involved in the management of patients with psoriasis.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

  • Review the pathophysiology of psoriasis, including genetic and cellular mechanisms, cytokines, and inflammatory processes
  • Describe the mechanisms of action, efficacy, and safety of approved and emerging biologics, along with their use in populations of color
  • Evaluate differences in presentation and treatment of special populations with psoriasis
  • Assess the disease burden and quality-of-life impact of psoriasis, along with tips on how to better manage them

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the treatment and management of patients with psoriasis.
Credits: 1.0 ANCC Contact Hour.

CNE Accreditation Statement: Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Dr. Crystal Aguh has received royalty fees from UptoDate Inc. and consultant fees from L’Oreal Inc.; contracted research from the Skin of Color Society.

CME Content Review
The content of this activity was independently peer reviewed.

The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Felecia Beachum, Program Manager for Med Learning Group has nothing to disclose.
Matthew Frese, MBA, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, CHCP Educational Development for Med Learning Group has nothing to disclose.
Russie Allen, Accreditation and Outcomes Coordinator has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes for Med Learning Group has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures.
2. Participate in the online activity.
3. Submit the evaluation form to Med Learning Group.
You will receive your certificate upon completion of your evaluation form, as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making ability before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at; info@medlearninggroup.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://medlearninggroup.com/privacy‐policy/

RELEASE DATE: October 3, 2019

EXPIRATION DATE: October 3, 2020

View Activity

Copyright © 2019 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.